2018


6. Article.
Emil Bulatov
, Regina Sayarova, Rimma Mingaleeva, Regina Miftakhova, Marina Gomzikova,
​Yuri Ignatyev, Alexey Petukhov, Pavel Davidovich, Albert Rizvanov, Nickolai Barlev /
Isatin-Schiff base-copper (II) complex induces cell death in p53-positive tumors //
Cell Death Discovery, 4: 103 (2018)
https://doi.org/10.1038/s41420-018-0120-z


5. Article. Quartile Q1. IF = 6.187
Aleksei Titov, Alexey Petukhov, Alena Staliarova, Dmitriy Motorin, Emil Bulatov, Oleg Shuvalov, Surinder M. Soond, Mauro Piacentini, Gerry Melino, Andrey Zaritskey & Nickolai A. Barlev / The biological basis and clinical symptoms of CAR-T therapy-associated toxicites //
Cell Death & Disease, 9, Article number: 897 (2018) 
https://doi.org/10.1038/s41419-018-0918-x


4. Article. Quartile Q2. Impact Factor = 2.664  
Emil Bulatov, Aygul Valiullina, Regina Sayarova, Albert Rizvanov / Promising new therapeutic targets for regulation of inflammation and immunity: RING-type E3 ubiquitin ligases //
Immunology Letters (2018) vol. 202, pp. 44-51
https://doi.org/10.1016/j.imlet.2018.08.001


3. Article. Quartile Q1. Impact Factor  = 4.439
Emil Bulatov, Almaz Zagidullin, Aygul Valiullina, Regina Sayarova, Albert Rizvanov / Small molecule modulators of RING-type E3 ligases: MDM and Cullin families as targets // 
Frontiers in Pharmacology. (2018) 9:450.
https://doi.org/10.3389/fphar.2018.00450


2. Book Chapter
Emil Bulatov. E3 Ubiquitin Ligases as Targets for Small Molecule Drug Discovery: Focusing on the Cullin Ring Family. Chapter in: Ubiquitin Proteasome System: A Review and Directions for Research. (2018) Nova Science Publishers.  
https://novapublishers.com/shop/ubiquitin-proteasome-system-a-review-and-directions-for-research/


1. Article. Quartile Q1. Impact Factor  = 4.439
G. Vafina, E. Zainutdinova, E. Bulatov, M.N. Filimonova / Endonuclease from Gram-Negative Bacteria Serratia marcescens Is as Effective as Pulmozyme in the Hydrolysis of DNA in Sputum// 
Frontiers in Pharmacology. (2018) Vol. 9. - Is. 114. - PP. 1-8. 
https://doi.org/10.3389/fphar.2018.00114